Merck Freed From Fosamax Product Liability Suits Based On US FDA Complete Response Letter
Executive Summary
District court dismisses more than 500 cases alleging Merck failed to warn of the risks of its osteoporosis drug, following path set by US Supreme Court in its ruling on the litigation three years ago.